This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. RP-6306 is an oral protein kinase, membrane-associated tyrosine/threonine 1 (PKMYT1) Inhibitor being developed for various solid tumors. PKMYT1, together…
molecule
7 months ago ●
5 mins read
with Dr. Romyr Dominique Contrary to popular belief, pharma is incredibly competitive, with dozens of companies often working on the…
Article
1 year ago ●
4 mins read
Context. BLU-945 (Blueprint Medicines) is an oral EGFR mutant inhibitor being developed for treatment-resistant non-small-cell lung cancer (NSCLC). Although three…
molecule
7 months ago ●
5 mins read
together with Dr. Naveed Yasin, Dr. Jennifer Huen, Dr. Vinicius Texeira, and Dr. Adrian Parodi In 2021 there were: 50…
Article
1 year ago ●
17 mins read
Context. SAGE-718 (Sage Therapeutics) is an oral N-methyl-d-aspartate receptor (NMDAR) Positive Allosteric Modulator (PAM) being developed for cognitive impairment in…
molecule
7 months ago ●
6 mins read
together with Dr. Naveed Yasin, Dr. Jen Huen, and Dr. Adrian Parodi There were four novel drugs approved by the…
Article
1 year ago ●
6 mins read
Load More
